Home
About Us
Aree
Contact us
Support

Home
About Us
Aree
Contact us
Support

daunorubicina Tag

Prospective randomized comparison of idarubicin and high-dose daunorubicin in induction chemotherapy for newly diagnosed AML

FOLLOW US #QODETHEMES

INSTAGRAM FEED

Mattioli HEALTH

Strada della Lodesana, 649 sx
43036 Fidenza (PR) Italy
Phone +039 0524 530383
E-mail: redazione@ematologiainprogress.it
P. IVA 00579710344
Privacy Policy
Cookie Policy

Mattioli HEALTH

Strada della Lodesana, 649 sx
43036 Fidenza (PR) Italy
Phone +039 0524 530383
E-mail: redazione@mattioli1885.com
P. IVA 00579710344
Privacy Policy
Cookie Policy
Termini e Condizioni